Dynamic Advisor Solutions LLC Crispr Therapeutics Ag Transaction History

Dynamic Advisor Solutions LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$43.23 - $73.83 $142,313 - $243,048	-3,292 Closed	0 $0
Q1 2022 Apr 11, 2022	SELL	$53.19 - $79.24 $35,371 - $52,694	-665 Reduced 16.81%	3,292 $207,000
Q4 2021 Jan 26, 2022	BUY	$70.09 - $111.29 $46,399 - $73,673	662 Added 20.09%	3,957 $300,000
Q3 2021 Oct 28, 2021	BUY	$110.2 - $156.64 $120,999 - $171,990	1,098 Added 49.98%	3,295 $369,000
Q2 2021 Aug 10, 2021	SELL	$100.84 - $161.89 $3,327 - $5,342	-33 Reduced 1.48%	2,197 $356,000
Q1 2021 Apr 27, 2021	SELL	$110.72 - $210.04 $141,389 - $268,221	-1,277 Reduced 36.41%	2,230 $272,000
Q4 2020 Feb 03, 2021	BUY	$79.67 - $173.23 $3,266 - $7,102	41 Added 1.18%	3,507 $537,000
Q3 2020 Oct 27, 2020	BUY	$78.5 - $100.64 $1,648 - $2,113	21 Added 0.61%	3,466 $290,000
Q2 2020 Aug 05, 2020	BUY	$38.5 - $76.05 $132,632 - $261,992	3,445 New	3,445 $253,000

490

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.18B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Dynamic Advisor Solutions LLC, based on Form 13F filings with the SEC.

Stay updated on Dynamic Advisor Solutions LLC with notifications on news.